Light Science Technologies' Injectaclad acquisition drives first major order episode artwork

EPISODE · May 5, 2026 · 6 MIN

Light Science Technologies' Injectaclad acquisition drives first major order

from Proactive - Interviews for investors · host Proactive Investors

Light Science Technologies Holdings PLC (AIM:LST, FRA:9FD) CEO Simon Deacon tells Proactive's Stephen Gunnion that the company has landed its first order since acquiring Injectaclad — a £410,000 contract to supply fire protection materials for a five-storey residential building. Deacon explains what sets Injectaclad apart: it eliminates the need to remove a building's façade, making it around ten times cheaper and six to seven times faster than traditional remediation, with no disruption to residents. The commercial opportunity is substantial. The company is working with 11 installers nationwide, has a quoted pipeline of around £130 million, and is targeting a market of over 40,000 UK buildings requiring remedial fire protection work, with improving approval timelines from the Building Safety Regulator helping projects move faster. For more insights like this, visit Proactive’s YouTube channel, like the video, subscribe, and enable notifications so you never miss future updates. #LightScienceTechnologies #Injectaclad #FireSafety #Cladding #BuildingSafety #ConstructionUK #StockMarketNews #SmallCapStocks #Infrastructure #FireProtection #UKHousing #InvestorNews #CEOInterview

Light Science Technologies Holdings PLC (AIM:LST, FRA:9FD) CEO Simon Deacon tells Proactive's Stephen Gunnion that the company has landed its first order since acquiring Injectaclad — a £410,000 contract to supply fire protection materials for a five-storey residential building. Deacon explains what sets Injectaclad apart: it eliminates the need to remove a building's façade, making it around ten times cheaper and six to seven times faster than traditional remediation, with no disruption to residents. The commercial opportunity is substantial. The company is working with 11 installers nationwide, has a quoted pipeline of around £130 million, and is targeting a market of over 40,000 UK buildings requiring remedial fire protection work, with improving approval timelines from the Building Safety Regulator helping projects move faster. For more insights like this, visit Proactive’s YouTube channel, like the video, subscribe, and enable notifications so you never miss future updates. #LightScienceTechnologies #Injectaclad #FireSafety #Cladding #BuildingSafety #ConstructionUK #StockMarketNews #SmallCapStocks #Infrastructure #FireProtection #UKHousing #InvestorNews #CEOInterview

NOW PLAYING

Light Science Technologies' Injectaclad acquisition drives first major order

0:00 6:01

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Proactive - Interviews for investors?

This episode is 6 minutes long.

When was this Proactive - Interviews for investors episode published?

This episode was published on May 5, 2026.

What is this episode about?

Light Science Technologies Holdings PLC (AIM:LST, FRA:9FD) CEO Simon Deacon tells Proactive's Stephen Gunnion that the company has landed its first order since acquiring Injectaclad — a £410,000 contract to supply fire protection materials for a...

Can I download this Proactive - Interviews for investors episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!